Braunschweig, Germany

Nicole Glaser




Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2001-2010

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nicole Glaser

Introduction

Nicole Glaser is a prominent inventor based in Braunschweig, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of four patents to her name, Glaser's work has the potential to impact various therapeutic areas.

Latest Patents

Among her latest patents, Glaser has developed tubulysins, which include methods for producing these compounds and tubulysin preparations. This invention relates to a compound characterized by a specific general formula, which has various meanings for its components. Additionally, she has worked on triazolo-epothilones, which are triazolo-thiazole analogues of epothilone A and epothilone B. These innovations showcase her expertise in creating complex chemical structures with potential therapeutic applications.

Career Highlights

Throughout her career, Nicole Glaser has been associated with notable organizations such as Bristol-Myers Squibb Company and Helmholtz-Zentrum für Infektionsforschung GmbH. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Glaser has worked alongside esteemed colleagues, including Gerhard Hoefle and Thomas Leibold. These collaborations have further enriched her research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Nicole Glaser's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…